Skin Cancer

A melanoma expert addresses the findings of two studies on the disease in children, adolescents and young adults, and shares ways in which they can protect themselves.

I have to admit I think about death a lot more since my two cancers, and I think that is OK.

A two-time, nine-year cancer survivor offers some suggestions to newly diagnosed cancer survivors.

A two-time cancer survivor shares the good that eventually came from her cancer experiences.

Here’s a sneak peek at what’s inside our Fall 2019 issue.

New therapies address difficult- to-treat advanced squamous cell carcinoma of the skin.

A two-time cancer survivor learns more about pancreatic cysts and discusses the value and cautions of genetic testing.

Cutaneous squamous cell carcinoma, caused by sun exposure or environmental toxins, is usually curable with surgery. Maybe that’s why many don’t realize that, if this cancer goes unchecked and untreated, it can grow, spread and become life-threatening.

A cancer survivor and clutter-clearing author shares autumnal time management tips.

One in two patients with metastatic melanoma is alive five years following treatment with Opdivo plus Yervoy, according to long-term follow-up of the phase 3 CheckMate 067 trial.

A two-time cancer survivor discusses her recently-discovered pancreatic cysts.

This two-time cancer survivor and clutter-clearing author struggles more thoughtfully with clutter since cancer.

A recent survey showed that most Americans do not know what cutaneous squamous cell carcinoma is and how severe the disease can be if it advances.

A two-time cancer survivor explores her thoughts on aging.

Cancer can switch you to a different track but does not necessarily derail you, says a two-time cancer survivor.

Nine years out from breast cancer and four years out from her melanoma, this cancer survivor still combats her fatigue.

There I was with my freshly darkened skin in the mirror (after a beautiful day out in the sun). What was I thinking? Oh yeah, I wasn’t thinking.

From hereditary cancer risk among twins to study findings in squamous cell carcinoma, here’s what is making headlines in the cancer space this week.

Figuring out whether to take targeted drugs or immunotherapy can be challenging for patients with metastatic melanoma that expresses a BRAF gene mutation, but there are rules of thumb that can help.

A nine-year breast cancer survivor and five-year melanoma survivor shares her thoughts on cancer survivorship with a side of mid-life crisis.

In a talk to people affected by melanoma, Michael McGrady described reassessing his values after cancer and how it changed the course of his life.

Following surgery with medication, combining immunotherapies or targeted drugs and adding radiation to immunotherapy can improve effectiveness in treating various stages of melanoma.

With greater longevity for survivors of melanoma comes the need to treat lingering side effects and monitor for cancer recurrences.

Immunotherapy may be giving hope to people living with rare skin cancer.

The Food and Drug Administration (FDA) approved Keytruda (pembrolizumab) – an immunotherapy agent – for the treatment of patients with resected, high-risk, stage 3 melanoma.

Here are tips for fellow cancer survivors to clear out cancer paraphernailia but keep important medical records.

Two-time cancer survivor suggests a careful approach when researching your own cancer.

A web-based intervention may help reduce harmful UV exposure and skin cancer risk in young adults, according to recent research.